Purpose: Stereotactic body radiation therapy (SBRT) allows for high radiation doses to be delivered to the pancreatic tumors with limited toxicity. Nevertheless, the respiratory motion of the pancreas introduces major uncertainty during SBRT. Ultrasound imaging is a non-ionizing, non-invasive, and real-time technique for intrafraction monitoring. A configuration is not available to place the ultrasound probe during pancreas SBRT for monitoring.
study showed high monitoring accuracy of the system, and the volunteer study showed feasibility of the clinical workflow.
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| INTRODUCTION
Pancreatic cancer remains one of the leading causes of cancer deaths in the United States. 1 Currently, the only curable treatment option has been surgical resection. However, most patients are unresectable, as only 20% of patients are surgical candidates. 2 For the unresectable patients, including the locally advanced and borderline resectable pancreatic cancer patients, the standard of care includes chemotherapy and radiation therapy. Although the optimal sequence, radiation technique, and total dose have not been well defined yet, recent advances in radiation therapy have improved the overall survival rate. 3 Our institution experience has previously been reported to utilize definitive five-fraction stereotactic body radiation therapy (SBRT) for locally advanced pancreatic cancer patients and borderline resectable pancreatic cancer patients. The report shows that chemotherapy of systemic gemcitabine followed by SBRT resulted in additional advancement toward optimizing patient outcomes. 4, 5 Some patients even had margin-negative resection and complete pathologic response with no remaining cancer cells found at the time of surgery. 6 Despite our institutional pancreas SBRT experience, early radiation therapy studies likely had higher toxicity rates due to the lack of fractionation, inadequate motion management, lack of image guidance, and lack of specific dose constraints for organs at risk. The motion of the pancreas due to patient respiration is the primary source of intrafraction treatment uncertainties. 7 Commonly employed motion management techniques include respiratory gating, active breathing coordinator (ABC), and abdominal compression. 8 Due to the possibility that the stomach and duodenum may be pushed into the target volume, resulting in increased radiation toxicity to these structures, it is not recommended to use abdominal compression techniques. These methods physically restrict the abdominal muscle movement with either a plate or belt that applies a significant amount of pressure. In addition to motion management, intrafraction monitoring is becoming available in daily clinical use as it can verify the target location during the radiation therapy and thus eliminate the intrafraction treatment uncertainty due to motion, even under motion management techniques. [9] [10] [11] Currently, several intrafraction motion monitoring methods have been developed. The predominant x-ray-based methods are limited either by the high level of imaging dose used for fluoroscopic imaging of small implanted markers or by the snapshot nature of the imaging data, such as those provided by cone-beam CT (CBCT). [12] [13] [14] The tracking of implanted electromagnetic transponders (i.e., Calypso)
avoids the use of ionizing radiation but is unsuitable for pancreatic cancer given the large size of the transponder and the invasive procedure needed to implant them. 15, 16 The recently introduced onboard MRI radiation systems offer a powerful real-time, non-invasive, and non-ionizing solution to guide and monitor SBRT of soft-tissue targets such as pancreatic cancer. 17, 18 However, it remains uncertain as to whether these advanced and expensive systems will be generally available to the community. As an alternative, ultrasound imaging has low cost, the ability for image enhancement with contrast agents, mobility to be shared among machines, and compatibility to add to any existing treatment room. [19] [20] [21] [22] [23] Ultrasound imaging has been previously developed for imageguided radiation therapy and is commercially available for prostate intrafraction monitoring. 24, 25 However, with the exception of recent efforts from the active robotic arm, [26] [27] [28] [29] [30] [31] ultrasound imaging-based intrafraction monitoring clinical studies are still limited to prostaterelated applications. This is mainly due to the lack of probe holders for other sites such as pancreas and liver and the lack of treatment planning method to accommodate probe placement during treatment. 27, 28 In this article, we introduce an arm-bridge system for intrafraction real-time motion monitoring during pancreas SBRT. We validated the image guidance workflow with volunteer study and studied the ultrasound monitoring accuracy using an ultrasound phantom and motion stage. We also investigated the impact of the probe placement in the treatment planning.
2 | METHODS Figure 1 shows a block diagram of the workflow of our study design.
Our proposed arm-bridge system was validated through the image guidance workflow. It was scanned and then segmented from the CT images. Previously treated pancreas SBRT patient CT images were fused with the segmented arm-bridge system to create virtual simulation CT. Two types of treatment plans, both IMRT and VMAT, were generated by following our clinical pancreas SBRT protocol criteria and avoiding the probes in the virtual simulation CT. They were compared with the clinically treated pancreas SBRT with IMRT plans.
In addition, a phantom study and volunteer study were performed to evaluate the accuracy of US monitoring. Participation of human subjects in the study was approved by the Internal Review Boards (IRBs) of the Johns Hopkins University School of Medicine where retrospective plans were analyzed and healthy volunteers were recruited.
2.A | Arm-bridge system
Our goal is to monitor the pancreas motion during the SBRT. Therefore, one of our top concerns for designing such system is its
interference with treatment delivery. The optimal system should have the minimal blockage for planned radiation beam delivery. However, the desired probe orientation should allow the maximum scanning volume rate from the ultrasound probe. To accommodate these requirements, we designed the probe holder system as an arm-bridge system.
The system consists of a couch top bridge, articulated arms, infrared tracker, and ultrasound probe case. The bridge has rails on the bottom, enabling it to be attached to different couch tops. Two passive arms are used in the design to allow both fast placement and fine-tuning of the probe position. Finally, a quick release mechanism on the probe case allows the user to detach the probe for freehand scanning. can then be fused to the planning CT in the Clarity image workstation. The short arm can be disconnected from the long arm from the adapter so that the user can operate the ultrasound probe freely during the initial scan. Once the optimal probe position and orientation is found by the user, the probe with the short arm can be connected back to the long arm. The user can then fine-tune the position and orientations of the probe (i.e., roll, pitch, and yaw) using the short arm.
The time taken to acquire an ultrasound image volume depends on the imaging depth (probe axial direction), the number of lines or sector width (probe lateral direction), and the mechanical sweeping angle or number of frames (probe elevational direction). Based on our clinical experience, the major motion for the pancreas is in the patient superior-inferior direction. In our design, the ultrasound probe is oriented so that the mechanical sweeping or the elevational direction is aligned with the patient left-right direction to minimize ultrasound acquisition time and allow maximized volume scanning rate in future studies. The ultrasound probe lateral direction is aligned with the patient superior-inferior direction in the treatment room.
2.B | Image guidance workflow validation
To validate our design in the setting of our pancreas patient image guidance workflow, we used the ABDFAN ultrasound phantom as
The study design workflow. The proposed arm-bridge system CT was validated for image guidance workflow. It was segmented and fused with previous patient pancreas CT to create the virtual simulation CT. The IMRT and VMAT plans from the virtual simulation CT were then compared with the prior clinically treated pancreas IMRT plan. To further validate the clinical setting, we tested the ultrasound monitoring system with volunteer study, in which three volunteers of different sizes were included. The volunteer and ultrasound system were set up on CT couch, and the couch was moved through CT bore to test clearance. Then, volunteer and ultrasound system were set up on treatment couch with ABC. The gantry was rotated to different angles to check clearance (Fig. 3 ).
2.C | Virtual simulation CT
To simulate the arm-bridge system during CT scan and the planning, we created virtual simulation CT by combining the armbridge system CT and previous patient simulation CT. We first setup the arm-bridge system together with an ultrasound phantom and then scanned both of them with CT. The ultrasound probe, probe case, infrared tracker, and the short arm were segmented from the CT image and then virtually placed on the patient 
2.D | Virtual simulation treatment planning
The clinically treated pancreatic SBRT plans in our institute used 10 or 11 coplanar IMRT beams, and ABC was used during simulation and treatment to constrain target movement. The plans were deliv- For each virtual simulation CT, both IMRT and VMAT plans were created, following the same prescription and constraints as clinically treated plans. The beam angles were selected to be at least 30°a
way from the probe axis on both left and right sides. All control points were ensured to have the leaf end position in any opening MLC at least 3 cm away from the probe contour in the beam's eye view. For IMRT plans, 10 or 11 step-and-shoot beams were used, which were similar to clinical plans. The beams were distributed in the angles outside probe axis plus/minus 30°. The maximum number of segments was set to 70. The maximum of optimization iterations was set as 50. For VMAT plans, two dynamic arcs were employed.
One arc covered from probe axis plus 30°to 180°in clockwise, the other arc covered from 182°to the angle as probe axis minus 30°in
anticlockwise. The gantry spacing was set as 2°and maximum delivery time was set for 300 s. Plans with virtual simulation CT use the same objective or constraint as clinical plans for PTV and OARs from dose volume histogram (DVH). In addition, to achieve fast dose falloff of SBRT, after the first round of optimization, the regions of interest (ROIs) of 100% and 50% of prescription dose were generated. If the dose fall off did not pass the protocol, the ROIs of 100%
and 50% of prescription dose were used as new objectives for a new round of optimization.
2.E | Plan evaluation
All virtual simulation plans were required to pass our pancreas More details about these constraints defined by our institution can be found in a recent publication. 5 In addition to the protocol, the following parameters were used to assess the plan quality: the minimal dose to 95% of the PTV (D95), minimal dose to 5% of the PTV (D5), mean dose to the PTV (Dmean), the conformal index (CI) which is the ratio between PTV and volume receiving dose larger than prescription dose, and homogeneity index (HI), which is the difference between D5 and D95, divided by Dmean. The mean and standard deviation of parameters listed here were calculated for clinically treated IMRT plan, virtual simulation IMRT plan, and VMAT plan. In addition, DVHs of clinically treated plan and virtual simulation plan were compared.
2.F | Ultrasound monitoring accuracy and reproducibility
The 
3.B | Virtual simulation, treatment planning, and plan evaluation
After the setup of phantom and arm-bridge system, a CT scan was performed for the whole setup as shown in Fig. 5(a) . The results of virtual simulation are shown in Fig. 7 , which includes an example of virtual simulation CT created for one of the previously treated patients. The arm-bridge system components (i.e., ultrasound probe, probe case, infrared tracker, and short arm) were manually segmented from the CT image. A rigid fusion using VelocityAI was performed to fuse the above arm-bridge system components to previous patient CT scan. The left part of Fig. 7 shows the original patient CT scan for the clinically treated plan. The result of the fused virtual simulation CT can be seen in the right part of Fig. 7 .
Ten treatment plan were made on virtual simulation CTs. All virtual simulation plans passed our institutional pancreas SBRT protocol criteria. Table 1 shows that for most of the PTV coverage parameters such as D95, V33, conformal index, and homogeneity index, differences between the clinically treated IMRT plan and the virtual simulation plans are not significant. For the Dmean and D5, the clinically treated IMRT plan shows larger deviation to the desired plan compared to the virtual simulation IMRT plans.
However, this result is similar to the virtual simulation VMAT plan.
For D95 and V33, the virtual simulation VMAT plan shows higher coverage than the virtual simulation IMRT plan. Based on OARs constraints (duodenum-V15/20, stomach-V15/20, liver-V12, and stomach-V12), as shown in Table 2 , there is no major difference between the clinically treated plan and the virtual simulation plans. For kidney-V12, clinically treated IMRT plan shows slightly more sparing to the kidney than the virtual simulation IMRT plan. For bowel-V15, virtual simulation VMAT plan shows more sparing than the clinically treated IMRT plan. Detailed dosimetric parameters for all 10 patients are shown in Tables 3-5 .
In general, for most of the parameters including the PTV coverage and the three most important OARs (duodenum-V15/20, stomach-V15/20, and bowel-V15/20), there are no significant differences between the virtual simulation plans and clinical plans. All virtual simulation plans pass the protocol requirement.
3.C | Ultrasound monitoring accuracy and ABC
Our experiment proved good ultrasound monitoring accuracy of our system. Figure 11 shows the setup of ultrasound phantom, motion platform, and arm-bridge system in the simulation room (left) and the Clarity Guide real-time monitoring of the ultrasound phantom motion (right). After aligned to the laser with the premark on the phantom surface, a monitoring reference ultrasound image was acquired at the simulated exhale phase from the motion platform. T A B L E 1 Dosimetric parameters of PTV coverage from clinically treated IMRT plans, virtual simulation IMRT plans, and virtual simulation VMAT plans. D 95: the minimal dose to 95% of the PTV, D5: minimal dose to 5% of the PTV, Dmean: mean dose to the PTV, CI: conformal index, the ratio between PTV and volume receiving dose larger than prescription dose, HI: homogeneity index, the difference between D5 and D95, divided by Dmean. Table 6 .
In the volunteer study, the reproducibility of 10 ABC breathholds of all three volunteers was less than 2 mm. Detailed results can be found in Table 7 . The data indicate our system could potentially provide accurate tracking of soft tissue in clinical settings.
| DISCUSSION
While we are accumulating more clinical evidence to support the benefit of pancreatic cancer treated with SBRT, intrafraction treatment uncertainty due to motion may be potentially improved by using real-time ultrasound monitoring. In addition to the similar advantage of being non-invasive, non-ionizing, and real-time,
T A B L E 3 Dosimetric parameters of all ten virtual simulated IMRT plans. D 95: the minimal dose to 95% of the PTV, D5: minimal dose to 5% of the PTV, Dmean: mean dose to the PTV, CI: conformal index, the ratio between PTV and volume receiving dose larger than prescription dose, HI: homogeneity index, the difference between D5 and D95, divided by Dmean. IMRT and VMAT radiation beams through the ultrasound sound probe, we found that the planning quality is not compromised. It is, therefore, possible to achieve the same planning quality as the clinical plans when the probe and the arm-bridge system are present.
However, there were several limitations to this study. Our design, mechanical clearance, imaging accessibility, probe stability, and deployment efficiency should be evaluated more comprehensively in a pilot study on patients. In addition, ultrasound imaging of the pancreas may not always be possible due to the bowel or stomach gas causing poor image quality. Patient education on diet at the initial consultation with nurses and physicians, and following diet restrictions are crucial to improving patient ultrasound imaging quality. During the phantom CT imaging in the simulation room and CBCT imaging in the treatment room, CT and CBCT images showed noticeable metal artifact from the probe as in Fig. 3 . To mitigate the metal artifact from the probe, we have worked on strategies with promising results such as using a mock probe. 27 Other groups also developed CT and CBCT reconstruction algorithms to reduce general metal artifact as in recent studies. 32 A clinical implementation of metal artifact reduction algorithm from such studies can help us to improve the image quality result from CT and CBCT with an ultrasound probe in placement. The speed of sound correction is a known issue for the accuracy of ultrasound imaging. Several groups have studied the accuracy and potential impact on ultrasound imaging. 33 In this study, we have not discussed the potential image degradation from the exit dose from radiation beam. It would be interesting to determine the dose level that can potentially degrade the image quality or damage the probe. In our study with the phantom and simulation CT, we did not include the soft-tissue deformation introduced by the probe weight. Our future study with clinical patients will allow us to better understand the impact of the probe weight on soft-tissue deformation, treatment planning, and ultrasound image quality.
| CONCLUSION
Our ultrasound system can potentially be used for real-time monitoring during pancreas SBRT. The phantom study showed high monitoring accuracy of the system, and the volunteer study showed and Elekta to J. W.
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